News

CHARLOTTESVILLE BIOTECH IS ON THE MOVE AND GROWING. THESE ARE THE LATEST UPDATES.

Cavion closes $26.1 MM Series A financing

Cavion, Inc. started off 2017 with a bang by announcing a $26.1 million venturing financing with Lilly Ventures, Novartis Venture Fund and Enso Ventures. The funding will be used  to continue Cavion’s development of  T-type calcium channel modulators for neurological... Read More +

HemoShear Therapeutics Appoints Head Of Research And Development

HemoShear Therapeutics announced the appointment of John E. Reardon, Ph.D. as Head of Research and Development. The full press release is available at the link below and at hemoshear.com/press-releases/Reardon. “We are proud that John will lead our children’s rare metabolic disease programs... Read More +